Nicholas R. Denny

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

Journal: Blood
Published: June 17, 2025

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.

Journal: Blood
Published: June 17, 2025

Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Journal: Blood
Published: December 13, 2024

Mapping chromatin structure at base-pair resolution unveils a unified model of cis-regulatory element interactions.

Mapping chromatin structure at base-pair resolution unveils a unified model of cis-regulatory element interactions.

Journal: Cell
Published: December 10, 2024

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.

Journal: Nature communications
Published: December 08, 2022

Direct correction of haemoglobin E β-thalassaemia using base editors.

Direct correction of haemoglobin E β-thalassaemia using base editors.

Journal: Nature communications
Published: July 04, 2022

Determining chromatin architecture with Micro Capture-C.

Determining chromatin architecture with Micro Capture-C.

Journal: Nature protocols
Published: April 30, 2022

DAT negative warm autoimmune haemolytic anaemia secondary to a mature cystic teratoma refractory to immunosuppressive therapy.

DAT negative warm autoimmune haemolytic anaemia secondary to a mature cystic teratoma refractory to immunosuppressive therapy.

Journal: BMJ case reports
Published: March 02, 2022

Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.

Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.

Journal: British journal of haematology
Published: October 13, 2021

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Journal: Nature genetics
Published: April 30, 2021

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.

Journal: British journal of haematology
Published: February 15, 2021

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification.

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification.

Journal: BMJ open
Published: July 09, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026